Results 41 to 50 of about 7,162 (150)

Budd-Chiari syndrome-acute-on-chronic liver failure with simultaneous thrombotic and non-thrombotic acute insults

International Journal of Gastrointestinal Intervention
A 21-year-old man presented with acute onset of jaundice, abdominal pain, ascites, and hepatomegaly, along with a history of Budd-Chiari syndrome previously treated with vena cava angioplasty.
Vinay Borkar, Mit Shah, Chintan Tailor, Shamshersingh Chauhan, Saiprasad Lad, Vikramaditya Rawat, Yatin Lunagariya, Shivani Chopra, Deepak Sasikumar, Meghraj Ingle   +9 more
doaj   +1 more source

Особенности развития и течения осложнений цирроза печени в зависимости от этиологического фактора [PDF]

, 2013
ВАРИКОЗНОЕ РАСШИРЕНИЕ ВЕНГЕПАТИТ ВИРУСНЫЙ ЧЕЛОВЕКАЖЕЛУДОКПИЩЕВОДПОРТОСИСТЕМНЫЙ ШУНТ ХИРУРГИЧЕСКИЙЦИРРОЗ ...
Бабаджанов, А. Ф., Девятов, А. В., Назыров, Ф. Г., Раимов, С. А.   +3 more
core  

Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis [PDF]

, 2018
BACKGROUND: Hepatosplenic schistosomiasis is an important cause of variceal bleeding in low-income countries. Randomised clinical trials have evaluated the outcomes of two categories of surgical interventions, shunts and devascularisation procedures ...
Brand, Martin, Ede, Chikwendu J, Nikolova, Dimitrinka   +2 more
core   +1 more source

Neuropsychological Aspects of Liver Disease and its Treatment [PDF]

, 2008
Liver disease can lead to serious impairment in cognitive functioning, through the development of a condition known as hepatic encephalopathy (HE). While gross impairment is clinically obvious, milder variants of the condition may escape detection at ...
O'Carroll, Ronan
core   +1 more source

Stentul metalic autoexpandabil– O nouă metodă de hemostază a varicelor esofagiene hemoragice [PDF]

, 2021
Varicele esofagiene complicate cu hemoragie reprezintă o afecţiune potenţial fatală a hipertensiunii portale. Hemoragia variceală acută este asociată cu o mortalitate de 30–50%.
Bunic, Gheorghe, Ghidirim, Gheorghe, Mişin, Igor, Zastavnitchi, Gheorghe   +3 more
core   +1 more source

Cardiovascular dysfunction in patients with liver cirrhosis [PDF]

, 2020
Hyperdynamic syndrome is a well-known clinical condition found in patients with cirrhosis and portal hypertension, characterized by increased heart rate and cardiac output, and reduced systemic vascular resistance and arterial blood pressure.
Francesco Purrello, Giuseppe Fede, Graziella Privitera, Luisa Spadaro, Tania Tomaselli   +4 more
core  

Liver surgery in cirrhosis and portal hypertension [PDF]

, 2016
The prevalence of hepatic cirrhosis in Europe and the United States, currently 250 patients per 100000 inhabitants, is steadily increasing. Thus, we observe a significant increase in patients with cirrhosis and portal hypertension needing liver ...
Hackl, Christina, Lang, Sven A., Renner, Philipp, Schlitt, Hans J.   +3 more
core   +1 more source

Oral Presentations

, 1995
HPB Surgery, Volume 9, Issue S1, Page 2-80, 1995.
wiley   +1 more source

Studies related to portal hypertension [PDF]

, 2002
Cirrhosis of the liver is a chronic disorder resulting from a variety of known and unknown aetiological factors, which lead to hepatocyte damage and death, regeneration of remaining hepatocytes and progressive fibrosis in a sequential manner.
Shah, Syed Hasnain Ali
core   +1 more source

Quantitative modeling of the physiology of ascites in portal hypertension [PDF]

, 2012
Although the factors involved in cirrhotic ascites have been studied for a century, a number of observations are not understood, including the action of diuretics in the treatment of ascites and the ability of the plasma-ascitic albumin gradient to ...
A Albillos, A Braillon, A Cardenas, A Escorsell, A Kashani, A Lenaerts, A Luca, A Paton, A Perello, AC Guyton, AE Dumont, AE Dumont, AE Dumont, AE Dumont, B Rippe, B Rippe, BA Runyon, BK De, C Bolton, CL Witte, CL Witte, CV Greenway, D Roulot, D Tripathi, David G Levitt, DC Schohn, E Kuntz, E Russi, E Tincani, EF Zotti, EH Starling, F Braet, F Wong, F Wong, FJ Dudley, FJ Dudley, FL Lieberman, FR Ibarra, G Garcia-Tsao, G Garcia-Tsao, G La Villa, G Pomier-Layrargues, G Pomier-Layrargues, G Romero, G Szabo, GA Laine, GA Morali, GJ Webster, H Jahn, H Krook, H Reynaert, HA Heit, HC Meng, HT Chiang, J Bosch, J Bosch, J Bosch, J Trotter, J Vlachogiannakos, J Zink, JA Barrowman, JA Schilling, JC Garcia-Pagan, JD Myers, JH Henriksen, JH Henriksen, JH Henriksen, JH Henriksen, JH Henriksen, JM Cereda, JM Rodriguez-Laiz, KP Moore, L Shear, M Campagnoli, M Casado, M Flessner, MF Abu-Hijleh, MH Rosner, MH Witte, Michael D Levitt, MJ Davis, ML Malbrain, O Simonsen, P Gentilini, P Gines, P Tandon, P Vlavianos, PC Johnson, R Banares, R Maass-Moreno, R Moreau, R Moreau, RA Mactier, RE Hyatt, RJ Groszmann, RJ Groszmann, RP Myers, RT Krediet, RW Gore, S Moller, S Moller, S Nitta, S Sen, S Sugano, S Takasaki, SK Baik, SK Khalid, T Aramaki, T Iwao, T Sakai, TD Boyer, U Thalheimer, V Arroyo, V La Mura, VC Cogger, VK Rocco, W Laleman, WG Rector Jr, WG Rector Jr, WS Cobb, WW Lautt, Y Katsuta, Y Shibayama, Y Tameda   +123 more
core   +3 more sources